2009

• Signed vaccine promotional contract with Hualan Biological

2008

• Texas Pacific Group (TPG) became Company's strategic investor
• Signed vaccine promotional contract with Sanofi?Pasteur
• Signed vaccine distribution and promotional contracts with CNBG
• Signed vaccine distribution contract with Wyeth
• Signed promotional contract with Astellas (Fujisawa)

2007

• Began construction of new manufacturing facility in Suzhou’s China-Singapore Suzhou Industrial Park

2006

• Expanded sales network of pharmaceutical products, including promoting NT Pharma branded Shu Si?
• Acquired GSP certified distributors in Beijing and Shanghai to expand distribution network

2005

• Signed distribution and promotional contracts with Pfizer
• Signed distribution and promotional contract with B.Braun
• Company entered into the manufacturing arena by acquiring GSP/GMP certified Suzhou No. 1 Pharmaceutical Co., Ltd. in Suzhou
• Two Shanghai subsidiaries received ISO9001 certification

2003～2004

• Established NT Pharma Logistics (Shanghai) Co., Ltd. in 2004
• Established GSP certified Hainan subsidiary in 2004 and began vaccine distribution business
• Became exclusive distributor of GSK vaccines in China
• Established logistics centers in Beijing, Suzhou and Guangzhou

1999～2002

• Signed distribution contracts with Roche and Bayer
• Expanded distribution network to cover 55 major and medium-sized cities in China
• Established logistics center in Shanghai Waigaoqiao in 2002
• Established GSP certified Guangdong subsidiary in 2002
• Established the Company’s major operations center in Shanghai in 2001

1996～1998

• Expanded scope of distribution business with SmithKline Beecham
• Established Guangzhou Office in 1996
• Established Shanghai Office in 1998
• Established Hainan Office in 1998

1995

• NT Pharma was founded by Mr. David Ng in Hong Kong and began cooperation with SmithKline Beecham as general agent for its prescription products in China